Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only. [electronic resource]
Producer: 20151026Description: 601-10 p. digitalISSN:- 1433-2965
- Absorptiometry, Photon
- Adult
- Biomarkers -- blood
- Bone Diseases, Metabolic -- complications
- Bone Remodeling -- drug effects
- Case-Control Studies
- Cross-Sectional Studies
- Cyclosporine -- pharmacology
- Female
- Fibroblast Growth Factor-23
- Fibroblast Growth Factors -- blood
- Glucocorticoids -- pharmacology
- Humans
- Immunosuppressive Agents -- pharmacology
- Lumbar Vertebrae -- diagnostic imaging
- Lupus Erythematosus, Systemic -- complications
- Male
- Middle Aged
- Osteoporosis -- complications
- Premenopause
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.